Dr. Williams previously worked in the same capacity at Osiris Therapeutics, according to a news release. She is a fellow in the American Institute for Medical and Biological Engineering.
“Michelle has been a thought leader in regenerative medicine for two decades,” Randy Mills, PhD, CEO of Aziyo, said in the release. “She has a track record of consistently developing commercially successful products, including Osteocel, the world’s first stem cell product with cumulative sales of over $1 billion. We believe her ability to develop great products, backed by strong science and through efficient use of capital, will create significant value for Aziyo.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
